DK1727551T3 - Farmaceutisk sammensætning omfattende et benzodiazepinderivat og en inhibitor af RSV-fusionsproteinet - Google Patents
Farmaceutisk sammensætning omfattende et benzodiazepinderivat og en inhibitor af RSV-fusionsproteinetInfo
- Publication number
- DK1727551T3 DK1727551T3 DK05728747T DK05728747T DK1727551T3 DK 1727551 T3 DK1727551 T3 DK 1727551T3 DK 05728747 T DK05728747 T DK 05728747T DK 05728747 T DK05728747 T DK 05728747T DK 1727551 T3 DK1727551 T3 DK 1727551T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibitor
- pharmaceutical composition
- fusion protein
- benzodiazepine derivative
- rsv fusion
- Prior art date
Links
- 125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 title abstract 2
- 108020001507 fusion proteins Proteins 0.000 title abstract 2
- 102000037865 fusion proteins Human genes 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0406279.0A GB0406279D0 (en) | 2004-03-19 | 2004-03-19 | Therapeutic compounds |
| PCT/GB2005/001029 WO2005089771A1 (en) | 2004-03-19 | 2005-03-18 | Pharmaceutical composition comprising a benzodiazepine derivative and a inhibitor of the rsv fusion protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1727551T3 true DK1727551T3 (da) | 2009-12-14 |
Family
ID=32118066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05728747T DK1727551T3 (da) | 2004-03-19 | 2005-03-18 | Farmaceutisk sammensætning omfattende et benzodiazepinderivat og en inhibitor af RSV-fusionsproteinet |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20070185096A1 (da) |
| EP (1) | EP1727551B1 (da) |
| JP (1) | JP2007529491A (da) |
| KR (1) | KR20070009630A (da) |
| CN (1) | CN100496499C (da) |
| AT (1) | ATE442145T1 (da) |
| AU (1) | AU2005224159B2 (da) |
| BR (1) | BRPI0507652A (da) |
| CA (1) | CA2557931A1 (da) |
| DE (1) | DE602005016532D1 (da) |
| DK (1) | DK1727551T3 (da) |
| ES (1) | ES2331479T3 (da) |
| GB (1) | GB0406279D0 (da) |
| PL (1) | PL1727551T3 (da) |
| PT (1) | PT1727551E (da) |
| RU (1) | RU2006136881A (da) |
| WO (1) | WO2005089771A1 (da) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0406282D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
| MX2009002019A (es) * | 2006-08-24 | 2009-03-09 | Novartis Ag | Derivados de 2-(pirazin-2-il)-tiazol y 2-(1h-pirazol-3-il)-tiazol asi como compuestos relacionados como inhibidores de la estearoil-coa-desaturasa (scd) para el tratamiento de trastornos metabolicos, cardiovasculares, y otros. |
| CA2662574A1 (en) | 2006-09-22 | 2008-03-27 | Novartis Ag | Heterocyclic organic compounds |
| WO2008074835A1 (en) | 2006-12-20 | 2008-06-26 | Novartis Ag | 2-substituted 5-membered heterocycles as scd inhibitors |
| JP2011520809A (ja) * | 2008-05-05 | 2011-07-21 | アムジエン・インコーポレーテツド | γセクレターゼモジュレーターとしての尿素化合物 |
| US9556236B1 (en) | 2012-11-29 | 2017-01-31 | University Of South Florida | Compositions and methods for treating respiratory syncytial virus infection |
| DK3324977T3 (da) | 2015-07-22 | 2022-10-17 | Enanta Pharm Inc | Benzodiazepinderivater som rsv-inhibitorer |
| EP3402799B1 (en) | 2016-01-15 | 2022-05-04 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as rsv inhibitors |
| GB201613942D0 (en) * | 2016-08-15 | 2016-09-28 | Univ Of Durham The | An antimicrobial compound |
| US10398706B2 (en) | 2017-01-06 | 2019-09-03 | Enanta Pharmaceuticals, Inc. | Heteroaryldiazepine derivatives as RSV inhibitors |
| CN110809472B (zh) * | 2017-02-16 | 2023-05-23 | 英安塔制药有限公司 | 用于制备苯二氮䓬衍生物的方法 |
| WO2018226801A1 (en) | 2017-06-07 | 2018-12-13 | Enanta Pharmaceuticals, Inc. | Aryldiazepine derivatives as rsv inhibitors |
| WO2019006291A1 (en) | 2017-06-30 | 2019-01-03 | Enanta Pharmaceuticals, Inc. | HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS |
| US11091501B2 (en) | 2017-06-30 | 2021-08-17 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as RSV inhibitors |
| WO2019046364A1 (en) * | 2017-08-29 | 2019-03-07 | Emory University | INHIBITORS OF SYNCYTIAL RESPIRATORY VIRUS (RSV) REPLICATION AND USES THEREOF |
| BR112020006334A2 (pt) * | 2017-09-29 | 2020-09-24 | Enanta Pharmaceuticals, Inc. | combinação de agentes farmacêuticos como inibidores de rsv |
| CA3080138A1 (en) | 2017-11-13 | 2019-05-16 | Enanta Pharmaceuticals, Inc. | Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives |
| US10647711B2 (en) | 2017-11-13 | 2020-05-12 | Enanta Pharmaceuticals, Inc. | Azepin-2-one derivatives as RSV inhibitors |
| WO2019199908A1 (en) | 2018-04-11 | 2019-10-17 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as rsv inhibitors |
| BR112021018335A2 (pt) | 2019-03-18 | 2021-11-23 | Enanta Pharm Inc | Derivados de benzodiazepina como inibidores de rsv |
| WO2020210246A1 (en) | 2019-04-09 | 2020-10-15 | Enanta Pharmaceuticals, Inc, | Heterocyclic compounds as rsv inhibitors |
| GB201911944D0 (en) * | 2019-08-20 | 2019-10-02 | Reviral Ltd | Pharmaceutical compounds |
| US11505558B1 (en) | 2019-10-04 | 2022-11-22 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
| AU2020357452B2 (en) | 2019-10-04 | 2026-01-29 | Enanta Pharmaceuticals, Inc | Antiviral heterocyclic compounds |
| GB201915273D0 (en) * | 2019-10-22 | 2019-12-04 | Reviral Ltd | Pharmaceutical compounds |
| GB201915932D0 (en) | 2019-11-01 | 2019-12-18 | Reviral Ltd | Pharmaceutical compounds |
| UY39032A (es) | 2020-01-24 | 2021-07-30 | Enanta Pharm Inc | Compuestos heterocíclicos como agentes antivirales |
| WO2022010882A1 (en) | 2020-07-07 | 2022-01-13 | Enanta Pharmaceuticals, Inc, | Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors |
| US11945824B2 (en) | 2020-10-19 | 2024-04-02 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as anti-viral agents |
| WO2022182861A1 (en) | 2021-02-26 | 2022-09-01 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
| US12612412B2 (en) | 2021-02-26 | 2026-04-28 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
| AR129003A1 (es) | 2022-04-07 | 2024-07-03 | Enanta Pharm Inc | Compuestos heterocíclicos antivirales |
| WO2023211997A1 (en) | 2022-04-27 | 2023-11-02 | Enanta Pharmaceuticals, Inc. | Antiviral compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4324794A (en) * | 1980-08-26 | 1982-04-13 | Research Triangle Institute | Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds |
| US4820834A (en) * | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
| EP0491218A1 (en) * | 1990-12-17 | 1992-06-24 | F. Hoffmann-La Roche Ag | Benzodiazepinones |
| US6489338B2 (en) * | 2000-06-13 | 2002-12-03 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrimidine antiviral agents |
| WO2003049688A2 (en) * | 2001-12-10 | 2003-06-19 | Bristol-Myers Squibb Company | Bis hydrochloride monohydrate salt of rsv fusion inhibitor |
| US6919331B2 (en) * | 2001-12-10 | 2005-07-19 | Bristol-Myers Squibb Company | Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| NZ538870A (en) * | 2002-09-20 | 2007-04-27 | Arrow Therapeutics Ltd | Benzodiazepine derivatives and pharmaceutical compositions containing them |
| GB0406282D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
-
2004
- 2004-03-19 GB GBGB0406279.0A patent/GB0406279D0/en not_active Ceased
-
2005
- 2005-03-18 DE DE602005016532T patent/DE602005016532D1/de not_active Expired - Fee Related
- 2005-03-18 CN CNB2005800089207A patent/CN100496499C/zh not_active Expired - Fee Related
- 2005-03-18 WO PCT/GB2005/001029 patent/WO2005089771A1/en not_active Ceased
- 2005-03-18 US US10/593,382 patent/US20070185096A1/en not_active Abandoned
- 2005-03-18 CA CA002557931A patent/CA2557931A1/en not_active Abandoned
- 2005-03-18 RU RU2006136881/15A patent/RU2006136881A/ru not_active Application Discontinuation
- 2005-03-18 PL PL05728747T patent/PL1727551T3/pl unknown
- 2005-03-18 BR BRPI0507652-8A patent/BRPI0507652A/pt not_active IP Right Cessation
- 2005-03-18 PT PT05728747T patent/PT1727551E/pt unknown
- 2005-03-18 DK DK05728747T patent/DK1727551T3/da active
- 2005-03-18 AT AT05728747T patent/ATE442145T1/de not_active IP Right Cessation
- 2005-03-18 AU AU2005224159A patent/AU2005224159B2/en not_active Ceased
- 2005-03-18 KR KR1020067021651A patent/KR20070009630A/ko not_active Withdrawn
- 2005-03-18 JP JP2007503412A patent/JP2007529491A/ja not_active Withdrawn
- 2005-03-18 ES ES05728747T patent/ES2331479T3/es not_active Expired - Lifetime
- 2005-03-18 EP EP05728747A patent/EP1727551B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ATE442145T1 (de) | 2009-09-15 |
| US20070185096A1 (en) | 2007-08-09 |
| JP2007529491A (ja) | 2007-10-25 |
| CN1933841A (zh) | 2007-03-21 |
| PT1727551E (pt) | 2009-10-08 |
| PL1727551T3 (pl) | 2010-02-26 |
| BRPI0507652A (pt) | 2007-07-10 |
| EP1727551B1 (en) | 2009-09-09 |
| DE602005016532D1 (de) | 2009-10-22 |
| CA2557931A1 (en) | 2005-09-29 |
| AU2005224159A1 (en) | 2005-09-29 |
| RU2006136881A (ru) | 2008-04-27 |
| AU2005224159B2 (en) | 2009-05-21 |
| CN100496499C (zh) | 2009-06-10 |
| ES2331479T3 (es) | 2010-01-05 |
| WO2005089771A1 (en) | 2005-09-29 |
| EP1727551A1 (en) | 2006-12-06 |
| KR20070009630A (ko) | 2007-01-18 |
| GB0406279D0 (en) | 2004-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1727551T3 (da) | Farmaceutisk sammensætning omfattende et benzodiazepinderivat og en inhibitor af RSV-fusionsproteinet | |
| CY1109523T1 (el) | Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα παραγωγο βενζοδιαζεπινης και εναν αναστολεα της πρωτεϊνης συντηξης rsv | |
| WO2006128184A3 (en) | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors | |
| PA8564901A1 (es) | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo | |
| LU92326I2 (fr) | Canakinumab et ses dérivés pharmaceutiquement acceptables (ILARIS) | |
| AU2003261434A1 (en) | Iminothiazolidinones as inhibitors of hcv replication | |
| EA200400991A1 (ru) | Фармацевтические композиции, содержащие ингибиторы протеазы вируса гепатита c | |
| LU92513I2 (fr) | Sofosbuvir et ses dérivés pharmaceutiquement acceptables (solvaldi) | |
| LU93093I2 (fr) | Nécitumumab et ses dérivés pharmaceutiquement acceptables (portrazza) | |
| HN2003000054A (es) | Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo (cetpi), a procedimientos de uso y a procedimientos de preparacion de las mismas. | |
| LU92517I2 (fr) | Delamanide et ses dérivés pharmaceutiquement acceptables | |
| TW200505484A (en) | Pharmaceutical compositions for hepatitis C viral protease inhibitors | |
| LU92871I2 (fr) | Fumarate de diméthyle et ses dérivés pharmaceutiquement acceptables (tecfidera) | |
| NO20043642L (no) | Heterocykiske tripeptider som hepatitt C inhibitorer | |
| DK1509232T3 (da) | Kombination af en NMDA-antagonist og acetylcholin-esterase inhibitorer til behandling af Alzheimers sygdom | |
| NO20061072L (no) | Doseringsformer som tilveiebringer kontrollert frigivning av kolesterylesteroverfonngsprotetntnhibttorer og umiddelbar frigivning av HMG-COA-reduktase-Inhibitor | |
| NO20024528L (no) | Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen | |
| CO5600999A2 (es) | Composiciones farmaceuticas que comprenden inhibidores de valsartan y endopeptidasa neutra | |
| DK1564210T3 (da) | 4-Oxoquinolinforbindelser og anvendelse deraf som HIV-integraseinhibitorer | |
| NO20052546D0 (no) | Substituert arylthiourea og relaterte forbindelser; inhibitorer av viral reproduksjon. | |
| BRPI0514372A (pt) | inibidores de tiazol de frutose 1, 6-bisfosfatase | |
| EE05385B1 (et) | LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon | |
| GB0308201D0 (en) | Novel compounds | |
| AR049274A1 (es) | Acido2-{[2-(2-metilaminopirimidin-4-il)-1h-indol-5-carbonil]amino}-3-(fenilpiridin-2-ilamino)propionico sustancialmente puro como inhibidor selectivo de la quinasa ikk-2 | |
| BR0306928A (pt) | Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace) |